In this issue:
Patient frailty affects functional use of haemodialysis vascular access
COVID-19 and the dialysis population
Chlorthalidone for hypertension in advanced CKD
Hyperkalaemia risk with finerenone
Conversion from calcineurin inhibitor- to belatacept-based immunosuppression in renal transplant recipients
Physical activity and function in patients with advanced CKD
A virtual home dialysis mentoring programme for nephrologists
Physical exercise improves cognitive function in older adults with stage 3–4 CKD
Prescribing patterns of SGLT2 inhibitors in patients with CKD
Clinical impact of hyperkalaemia-related discontinuation of RAAS inhibitors in CKD patients
Adherence to physician visit recommendations in people identified with CKD on screening
Please login below to download this issue (PDF)